CheckMyRecalls

Cipla USA, Inc. recalls Budesonide Inhalation Suspension

Published
30 Jul 2025
Units affected
13,680 ampoules
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

Brand / company
Cipla USA, Inc.
Codes / lots
Batch # 4IA0505, Exp 09/31/2026
Distribution
Distributed Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 30 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.